Antonina Sergorodceva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Antonina Sergorodceva has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Andrey A. Vodyashkin
Bauman Moscow State Technical University, Moscow, Russia
2 shared publications Alexey Timofeev
RUDN University, 117198, Moscow, Russia
1 shared publication- Dovlet T. Rejepov
Nanotechnology Scientific and Educational Center, Institute of Biochemical Technology and Nanotechnology, Peoples’ Friendship University of Russia n.a. P. Lumumba (RUDN), Miklukho-Maklaya St. 6, Moscow 117198, Russia
1 shared publication - Elena D. Nikolskaya
Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, Russia
1 shared publication - Leonid A. Butusov
RUDN University, 117198, Moscow, Russia
1 shared publication - Margarita Chirkina
N.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119334, Moscow, Russia
1 shared publication
Latest Publications
- 1 December 2023
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 53 (3) , 1048-1057
Synthesis and activation of pH-sensitive metal–organic framework Sr(BDC)∞ for oral drug delivery
Metal–organic frameworks (MOFs) are widely used in the biomedical industry. In this study, we developed a new method for obtaining a metal–organic structure of strontium and terephthalic acid, Sr(BDC), and an alternative activation method for removing DMF from the pores. Sr(BDC) MOFs were successfully prepared and characterized by XRD, FTIR, TGA, and SEM. The importance of the activation steps was confirmed by TGA, which showed that the Sr(BDC)(DMF) sample can contain up to a quarter of the solvent (DMF) before activation. In our study, IR spectroscopy confirmed the possibility of removing DMF by ethanol treatment from the Sr-BDC crystals. A comparative analysis of the effect of the activation method on the specific surface and pore size of Sr-BDC and its sorption properties using the model drug doxorubicin showed that due to the undeveloped surface of the Sr-(BDC)(DMF) sample, it is not possible to obtain an adsorption isotherm and determine the pore size distribution, thus showing the importance of the activation step. Cytotoxicity and apoptosis assays were carried out to study the biological activity of MOFs, and we observed relatively low toxicity in the tested concentration range after 48 h, with over 92% cell survival for Sr(BDC)(DMF) and Sr(BDC)(260 °C), with a decrease only in the highest concentration (800 mg L−1). Similar results were observed in our apoptosis assays, as they revealed low apoptotic population generation of 2.52%, 3.23%, and 2.77% for Sr(BDC)(DMF), Sr(BDC) and Sr(BDC)(260 °C), respectively. Overall, the findings indicate that ethanol-activated Sr(BDC) shows potential as a safe and effective material for drug delivery.
- 1 December 2023
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 53 (3) , 1048-1057
Synthesis and activation of pH-sensitive metal–organic framework Sr(BDC)∞ for oral drug delivery
Metal–organic frameworks (MOFs) are widely used in the biomedical industry. In this study, we developed a new method for obtaining a metal–organic structure of strontium and terephthalic acid, Sr(BDC), and an alternative activation method for removing DMF from the pores. Sr(BDC) MOFs were successfully prepared and characterized by XRD, FTIR, TGA, and SEM. The importance of the activation steps was confirmed by TGA, which showed that the Sr(BDC)(DMF) sample can contain up to a quarter of the solvent (DMF) before activation. In our study, IR spectroscopy confirmed the possibility of removing DMF by ethanol treatment from the Sr-BDC crystals. A comparative analysis of the effect of the activation method on the specific surface and pore size of Sr-BDC and its sorption properties using the model drug doxorubicin showed that due to the undeveloped surface of the Sr-(BDC)(DMF) sample, it is not possible to obtain an adsorption isotherm and determine the pore size distribution, thus showing the importance of the activation step. Cytotoxicity and apoptosis assays were carried out to study the biological activity of MOFs, and we observed relatively low toxicity in the tested concentration range after 48 h, with over 92% cell survival for Sr(BDC)(DMF) and Sr(BDC)(260 °C), with a decrease only in the highest concentration (800 mg L−1). Similar results were observed in our apoptosis assays, as they revealed low apoptotic population generation of 2.52%, 3.23%, and 2.77% for Sr(BDC)(DMF), Sr(BDC) and Sr(BDC)(260 °C), respectively. Overall, the findings indicate that ethanol-activated Sr(BDC) shows potential as a safe and effective material for drug delivery.
- Open Access
- 28 August 2021
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 10 (3) , 176-187
Biomedical Applications of Silver Nanoparticles (Review)
Introduction. Silver nanoparticles have unique physicochemical properties and can be used for the diagnosis and treatment of various kinds of infections, oncological diseases, as well as drug delivery. The review presents an analysis of scientific literature on the use of silver nanoparticles for biomedical purposes.Text. The review discusses the perspectives of the silver nanoparticles use in the treatment of oncological diseases as a carrier of drugs, as well as the direct manifestation of their cytotoxic effect on cancer cells. Also, there is considered the use of silver nanoparticles for imparting or enhancing the antibacterial effects of dressings and dental materials. The mechanism of action of silver nanoparticles against viruses is considered. This research presents the use of composite materials containing silver nanoparticles for biomedical purposes.Conclusion. On the basis of the literature data analysis, carried out by the authors, there are shown possibilities of the nanotechnology achievements for the application in medicine.
- 28 August 2021
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 10 (3) , 176-187
Open AccessBiomedical Applications of Silver Nanoparticles (Review)
Introduction. Silver nanoparticles have unique physicochemical properties and can be used for the diagnosis and treatment of various kinds of infections, oncological diseases, as well as drug delivery. The review presents an analysis of scientific literature on the use of silver nanoparticles for biomedical purposes.Text. The review discusses the perspectives of the silver nanoparticles use in the treatment of oncological diseases as a carrier of drugs, as well as the direct manifestation of their cytotoxic effect on cancer cells. Also, there is considered the use of silver nanoparticles for imparting or enhancing the antibacterial effects of dressings and dental materials. The mechanism of action of silver nanoparticles against viruses is considered. This research presents the use of composite materials containing silver nanoparticles for biomedical purposes.Conclusion. On the basis of the literature data analysis, carried out by the authors, there are shown possibilities of the nanotechnology achievements for the application in medicine.